Difference between revisions of "Part:BBa K3771078"
Marvinang02 (Talk | contribs) |
|||
Line 19: | Line 19: | ||
<img src="https://2021.igem.org/wiki/images/c/c9/T--NCKU_Tainan--taurine_pathway_1.png" style="width:50%;"> | <img src="https://2021.igem.org/wiki/images/c/c9/T--NCKU_Tainan--taurine_pathway_1.png" style="width:50%;"> | ||
</div> | </div> | ||
− | |||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
<br><b style="font-size:1.3rem">Usage</b> | <br><b style="font-size:1.3rem">Usage</b> | ||
<br> | <br> | ||
− | + | ||
+ | |||
+ | <br>CS was used in in vivo testing of taurine production. The sequence for CS enzyme and <i>trc</i> promoter were ligated and transformed into <i>E. coli</i> to calculate taurine production using high-performance liquid chromatography (HPLC). <br> | ||
+ | |||
+ | <div style="width=100%; display:flex; align-items: center; justify-content: center;"> | ||
+ | <img src="https://2021.igem.org/wiki/images/a/aa/T--NCKU_Tainan--3.png" style="width:35%;"> | ||
+ | </div> | ||
+ | <p>Fig. 2 Taurine production of Ptrc-cdo1 +PlacI-csad +Ptrc-cs in different growth mediums.</p> | ||
+ | |||
<br><b style="font-size:1.3rem">Characterization</b> | <br><b style="font-size:1.3rem">Characterization</b> | ||
<br> | <br> | ||
+ | <div style="width=100%; display:flex; align-items: center; justify-content: center;"> | ||
+ | <img src="https://2021.igem.org/wiki/images/3/39/T--NCKU_Tainan--CS-PCR.png" style="width:35%;"> | ||
+ | </div> | ||
+ | <p align="center">Fig. 1 Confirmation of <i>cs</i> fragment by PCR. M: Marker; Lane 1: <i>cs</i> (1272 bp)</p> | ||
+ | |||
<div style="width=100%; display:flex; align-items: center; justify-content: center;"> | <div style="width=100%; display:flex; align-items: center; justify-content: center;"> | ||
<img src="https://2021.igem.org/wiki/images/e/e3/T--NCKU_Tainan--CS-Vactor-digestion.png" style="width:35%;"> | <img src="https://2021.igem.org/wiki/images/e/e3/T--NCKU_Tainan--CS-Vactor-digestion.png" style="width:35%;"> |
Revision as of 03:13, 19 October 2021
Ptrc-CS
Description
Ptrc-cs is a composite part consisting of the trc promoter and the cs sequences. This part was used in in vivo testing of taurine production. The sequence for cs and trc promoter were ligated and transformed into E. coli to calculate taurine production using high-performance liquid chromatography (HPLC).
Biology
trc promoter constitutively facilitates the expression of CS enzyme.
Usage
CS was used in in vivo testing of taurine production. The sequence for CS enzyme and trc promoter were ligated and transformed into E. coli to calculate taurine production using high-performance liquid chromatography (HPLC).
Fig. 2 Taurine production of Ptrc-cdo1 +PlacI-csad +Ptrc-cs in different growth mediums.
Characterization
Fig. 1 Confirmation of cs fragment by PCR. M: Marker; Lane 1: cs (1272 bp)
Fig. 2 Confirmation of pSUI fragment by digestion. M: Marker; Lane 1: pSUI (3664 bp)
Fig. 3 Transformation/CS in DH5α
Fig. 4 Confirmation of cs fragment by colony PCR. M: Marker; Lane 1~6: Different colonies of pSUI-Ptrc-CS (1272 bp)
Fig. 5 Confirmation of pSUI-Ptrc-CS by digestion. M: Marker; Lane 1: Colony of pSUI-Ptrc-CS
Fig. 6 Confirmation of the protein expression of CS M: Marker; Lane 1: CS in DH5α with induction (~46 kDa)
References
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI.rc site found at 580